Six technologies awarded “Innovation open call” at NHS Cancer Programme in England

18

May 2023

On April 28, 2023, the NHS Cancer Programme awarded £12.1 million to six innovations that improve the early detection and diagnosis of cancer. Awarded medical devices, in-vitro diagnostics, and digital health solutions are used to diagnose bowel, skin, liver, breast, ovarian, and esophageal cancer.

NHS Cancer Programme, in partnership with SBRI Healthcare and Accelerated Access Collaborative, introduced an annual “Innovation open call” in 2021 to identify and support the most promising technologies to deliver NHS Long Term Plan ambitions for cancer. Funding is provided to fast-track innovations that have proven their efficacy and clinical effectiveness and are ready for real-world testing and rollout. The first innovation call winners were announced in February 2022.

The second call, launched in 2022, invited applications from single organizations based in the UK or EU from the private, public, and third sectors, including companies, charities, universities, and NHS providers. The eligible technologies included medical devices, in-vitro diagnostics, digital health solutions, behavior interventions, software, artificial intelligence, and new models of care.

The awarded technologies will be funded over the next 18 months to support the rollout and real-world testing. Some examples are provided below:

  • Non-endoscopic test (by Cyted) for the earlier detection of esophageal cancer is transforming the care pathway for people with chronic gastroesophageal reflux. Project CYTOPRIME2 will test patients at risk of cancer in primary and community care across the East of England, North West Coast, and Wessex Cancer Alliance regions;
  • Elecsys GAAD algorithm (by Roche Diagnostics) for early hepatocellular carcinoma (HCC) detection in routine practice combines blood tests with gender and age.

Other awarded innovations are used to diagnose bowel, skin, breast, and ovarian cancer.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

08

Jun 2023

In the period of April-May 2023, the Galician Agency for Health Technology Assessment (AVALIA-T) initiated the five health technology assessments referred to IVD, nephrology and urology, obstetrics and gynecology, pulmonary and airways as well as surgical procedures technology groups. The assessments on stereotactic virtual navigation system for percutaneous puncture as well as tumor ablation and invasive telemonitoring of pulmonary pressure in patients with heart failure were released.

Read more

07

Jun 2023

In May 2023, the National Institute for Health and Care Excellence (NICE) published one new Interventional Procedure Guidance (intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries), two new Diagnostic Guidance (MRI fusion biopsy systems for diagnosing prostate cancer, automated ankle-brachial pressure index measurement devices to detect peripheral arterial disease), and three new Health Technology Evaluations (Digitally enabled therapies for adults with anxiety disorders / with depression, and point-of-care tests for urinary tract infections). Also, four clinical guidelines were updated.

Read more

05

Jun 2023

In May 2023, NICE announced that the Medtech innovation briefing (MIB) program was discontinued. MIBs were a part of the advice program at NICE commissioned by NHS England in 2014 to support the 5-Year Forward View and accelerate innovations. NICE will now focus on introducing new approaches to evaluating the most promising health technologies.

Read more

01

Jun 2023

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

Read more

30

May 2023

On April 5, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of thirty-five applications for Innovation Funding of healthcare research projects were accepted. A total of 231 applications were received in response to the funding announcement of June 27, 2022 (changed on September 20, 2022), and thirty-five of them were accepted.

Read more